Search research articles
Contact Us
Filters
Showing results (231-240 of 252) with videos related to
Page
of 26
Sort By:
Life Sciences
|
November 24, 1998
The effects of diminishing albumin binding to some Endothelin receptor antagonists
B G Szczepankiewicz, R B Bal, T W von Geldern, et al.
British Journal of Cancer
|
October 15, 2014
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study
S-H Chien, C-J Liu, Y-C Hong, et al.
International Journal of Colorectal Disease
|
May 18, 2001
Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer
W S Wang, J K Lin, T C Lin, et al.
Japanese Journal of Clinical Oncology
|
February 24, 2001
Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiency
M H Yang, C C Yen, Y H Chang, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity
T W von Geldern, A S Tasker, B K Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan
J-Y You, K-H Chi, M-H Yang, et al.
Journal of Medicinal Chemistry
|
January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists
A S Tasker, B K Sorensen, H S Jae, et al.
Japanese Journal of Clinical Oncology
|
January 13, 2001
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience
J K Lin, W S Wang, R K Hsieh, et al.
Blood Cancer Journal
|
October 16, 2012
How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?
H-N Lin, C-Y Liu, J-T Pai, et al.
Diabetes
|
May 1, 2013
Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol
Michael R Rickels, Chengyang Liu, Richard D Shlansky-Goldberg, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 252) with videos related to
Sort By:
Page
of 26
Life Sciences
|
November 24, 1998
The effects of diminishing albumin binding to some Endothelin receptor antagonists
B G Szczepankiewicz, R B Bal, T W von Geldern, et al.
British Journal of Cancer
|
October 15, 2014
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study
S-H Chien, C-J Liu, Y-C Hong, et al.
International Journal of Colorectal Disease
|
May 18, 2001
Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer
W S Wang, J K Lin, T C Lin, et al.
Japanese Journal of Clinical Oncology
|
February 24, 2001
Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiency
M H Yang, C C Yen, Y H Chang, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivity
T W von Geldern, A S Tasker, B K Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2004
Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan
J-Y You, K-H Chi, M-H Yang, et al.
Journal of Medicinal Chemistry
|
January 31, 1997
Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists
A S Tasker, B K Sorensen, H S Jae, et al.
Japanese Journal of Clinical Oncology
|
January 13, 2001
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience
J K Lin, W S Wang, R K Hsieh, et al.
Blood Cancer Journal
|
October 16, 2012
How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?
H-N Lin, C-Y Liu, J-T Pai, et al.
Diabetes
|
May 1, 2013
Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol
Michael R Rickels, Chengyang Liu, Richard D Shlansky-Goldberg, et al.
Page
of 26